vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
20.00
-0.20 (-0.99%)
Feb 24, 2025, 11:59 AM EST - Market open
vTv Therapeutics Market Cap
vTv Therapeutics has a market cap or net worth of $63.79 million as of February 24, 2025. Its market cap has increased by 144.42% in one year.
Market Cap
63.79M
Enterprise Value
22.99M
1-Year Change
144.42%
Ranking
Category
Stock Price
$20.00
Market Cap Chart
Since July 30, 2015, vTv Therapeutics's market cap has decreased from $357.30M to $63.79M, a decrease of -82.15%. That is a compound annual growth rate of -16.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 64.40M | 46.36% |
| Dec 31, 2024 | 44.00M | 46.18% |
| Dec 29, 2023 | 30.10M | -56.57% |
| Dec 30, 2022 | 69.30M | -22.66% |
| Dec 31, 2021 | 89.60M | -34.79% |
| Dec 31, 2020 | 137.40M | 34.97% |
| Dec 31, 2019 | 101.80M | -5.74% |
| Dec 31, 2018 | 108.00M | -45.23% |
| Dec 29, 2017 | 197.20M | 24.42% |
| Dec 30, 2016 | 158.50M | -29.08% |
| Dec 31, 2015 | 223.50M | -37.45% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |